Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
I have sonicated the DNA down to 100-300 bp, and then performed sequence capture with Nimblegen arrays and sequenced on the Solexa systems. Works fine, should work as well with the SOLiD system or ?
-
covaris and sequence capture
The Agilent method looks interesting to us as well. Also, the Covaris usually comes with the SOLiD so no extra cost there and the amount of data is still 1-2 orders of magnitude more for SOliD than even Titanium per run - albeit some increase is needed to get same coverage.
Leave a comment:
-
Also, Agilent will have a seq-cap technology on the market soon. Don't know many details...
Leave a comment:
-
Titanium around the corner
You can concatamerise the Nimblegen Seqcap 500-mers and shear them with a Covaris instrument down to <= 100 bp then ligate on P1 and P2. You can bioinformatically remove the partially sequenced Nimblegen adaptors later in silico. Pretty damn messy solution but size reduction is required to get high density sequencing from Solexa and SOLiD after Nimblegen seqcap (see Hodges et al., 2007 in Nat Meth). BTW, the Covaris costs $$$. Also, 454/Roche will have the "Titanium" upgrade available soon for 454 FLX with over 5x more bases sequenced for less money.
We were investigating post-capture size reduction methods to use Solexa/SOLiD but decided to ditch that idea after we heard about Titanium. We have access to a 454 FLX machine - so that also swayed our judgement.
Leave a comment:
-
Target enrichment technologies for ABI SOLiD?
Hi
my group is involved in a national project to develop a genomic platform for cancer research. while Nimblegen has developed target enrichment chip for the Genome Sequencer 20, nothing similar has been done for the SOLiD system, as far as I know. Does anybody know something more about this topic?
thank you all
BuardoTags: None
Latest Articles
Collapse
-
by seqadmin
The complexity of cancer is clearly demonstrated in the diverse ecosystem of the tumor microenvironment (TME). The TME is made up of numerous cell types and its development begins with the changes that happen during oncogenesis. “Genomic mutations, copy number changes, epigenetic alterations, and alternative gene expression occur to varying degrees within the affected tumor cells,” explained Andrea O’Hara, Ph.D., Strategic Technical Specialist at Azenta. “As...-
Channel: Articles
07-08-2024, 03:19 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Yesterday, 06:46 AM
|
0 responses
9 views
0 likes
|
Last Post
by seqadmin
Yesterday, 06:46 AM
|
||
Started by seqadmin, 07-24-2024, 11:09 AM
|
0 responses
26 views
0 likes
|
Last Post
by seqadmin
07-24-2024, 11:09 AM
|
||
Started by seqadmin, 07-19-2024, 07:20 AM
|
0 responses
159 views
0 likes
|
Last Post
by seqadmin
07-19-2024, 07:20 AM
|
||
Started by seqadmin, 07-16-2024, 05:49 AM
|
0 responses
127 views
0 likes
|
Last Post
by seqadmin
07-16-2024, 05:49 AM
|
Leave a comment: